vector icon vector icon
Back
Message sent successfully
vector icon vector icon
vector icon

Nurami

Modernizing Soft Tissue Repair
Nurami harnesses nanofibers and novel biomaterials to modernize soft tissue surgical repair.
Nurami’s proprietary, electrospun-based platform technology enables the creation of an innovative category of bio surgical implants to seal and heal wounds effectively. These advanced products address complications associated with current soft tissue implants, such as dangerous leaks, and promote healthy tissue formation such as Dura repair as well as other tissue recovery processes.
Read more
Nurami
ArtiFascia®
ArtiFascia® is a next-generation Dural repair implant that provides watertight closure and fosters dura regeneration, in a thin, pliable, biomimetic, suturable, easy to handle graft.
Learn More
ArtiFascia ArtiFascia
ArtiFascia® is the first and only device with a 2-in 1 design: nanofibers provide a biomimetic scaffold that fosters healing + an integrated, thin film that reduces leaks.
ArtiFascia® is available  in the US market (510k cleared)
ArtiFascia® has successfully completed an 85-patient clinical study

Advantages

Porous scaffold designed to support regeneration
Porous scaffold designed to support regeneration
Fosters regeneration and healing over a porous biomimetic scaffold
Fosters regeneration and healing over a porous biomimetic scaffold
Exceptional strength and flexibility
Exceptional strength and flexibility
Helps prevent dural repair complications
Helps prevent dural repair complications

Achievements

Strong IP
Strong IP
Regulatory approval (510k)
Regulatory approval (510k)
Commercially available
Commercially available
Excellent clinical evidence
Excellent clinical evidence
figure

News

Nurami Accepted to the MedTech Innovator Program
Monday, 03 Jun 2024
Nurami Accepted to the MedTech Innovator Program
Great Appearance at AANS 2024 in Chicago
Thursday, 23 May 2024
Great Appearance at AANS 2024 in Chicago
New article published on ArtiFascia: Neural tissue tolerance to synthetic dural mater graft implantation – read more!
Thursday, 07 Mar 2024
New article published on ArtiFascia: Neural tissue tolerance to synthetic dural mater graft implantation – read more!
Nurami Accepted to the MedTech Innovator Program
Monday, 03 Jun 2024
Nurami Accepted to the MedTech Innovator Program
Great Appearance at AANS 2024 in Chicago
Thursday, 23 May 2024
Great Appearance at AANS 2024 in Chicago
New article published on ArtiFascia: Neural tissue tolerance to synthetic dural mater graft implantation – read more!
Thursday, 07 Mar 2024
New article published on ArtiFascia: Neural tissue tolerance to synthetic dural mater graft implantation – read more!
First ArtiFascia Dura repair procedures carried out in the US
Friday, 16 Feb 2024
First ArtiFascia Dura repair procedures carried out in the US
Iron Nation invests in Nurami Medical
Thursday, 25 Jan 2024
Iron Nation invests in Nurami Medical
View More

Upcoming Events

Nurami will be at annual CNS congress in Houston
30 Sep- 2 Oct, 2024 Houston, Texas
Nurami will be at annual CNS congress in Houston
Nurami to Attend AANS 2024 in Chicago
May 3-May 6, 2024 Chicago
Nurami to Attend AANS 2024 in Chicago
Nurami Medical has been accepted to the In-Ventech Growth Stage Program
May 08 - May 11, 2023 Caesarea
Nurami Medical has been accepted to the In-Ventech Growth Stage Program
Nurami will be at annual CNS congress in Houston
30 Sep- 2 Oct, 2024 USA
Nurami will be at annual CNS congress in Houston
Nurami to Attend AANS 2024 in Chicago
May 3-May 6, 2024 United States
Nurami to Attend AANS 2024 in Chicago
Nurami Medical has been accepted to the In-Ventech Growth Stage Program
May 08 - May 11, 2023 Israel
Nurami Medical has been accepted to the In-Ventech Growth Stage Program
View More

Contact us

Israel
USA
Nurami Medical Ltd. HQ
Israel
Nurami Medical Ltd. HQ
36 Ha-Namal St., Haifa, Israel
Nurami Medical INC.
USA
Nurami Medical Inc.
2436 Emrick Boulevard,
Bethlehem, PA 18020, USA
Message sent successfully
Skip to content